Global Fluorescence Immunoassay Poc Analyzers Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Fluorescence Immunoassay Poc Analyzers Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Fluorescence Immunoassay Analyzer is an analyzer that based on detection of fluorescence emitted during an immunoassay with antigen-antibody interaction. Fluorescence Immunoassay Analyzer works with certain fluorescent reagents. It’s for in vitro diagnosis professionals and Point of Care Use. It may be used in outpatient or emergency departments, clinical departments or medical services (such as community health centers), or medical center, etc. Fluorescence Immunoassay Poc Analyzer offers the advantages of high accuracy, strong stability and fast results.

Market Overview:

The latest research study on the global Fluorescence Immunoassay Poc Analyzers market finds that the global Fluorescence Immunoassay Poc Analyzers market reached a value of USD 837.64 million in 2022. It’s expected that the market will achieve USD 1268.05 million by 2028, exhibiting a CAGR of 7.16% during the forecast period.

Influence of COVID-19 Outbreak on Fluorescence Immunoassay Poc Analyzers Industry Development

In order to curb the COVID-19 epidemic, most countries have introduced many policies, including border blockade and social distancing. The epidemic prevention and control measures will affect the flow of people and activities, and in turn affect logistics, making the production of manufacturing, especially labor-intensive industries, affected by the supply of raw materials and labor shortages.

For the Fluorescence Immunoassay Poc Analyzers industry, the blockade policy will affect the supply of raw materials and export trade of products. The social distancing policy may have a great impact on the production of products, especially for some small factories, they will spend more money to maintain production during the epidemic, and factories may face the risk of closure in some areas. With the gradual control of the epidemic, some factories began to resume operation. However, while operating production, enterprises need to protect the life and health of employees, such as purchasing masks, disinfectants and other epidemic prevention materials, disinfecting the working environment before and after the production, and testing the body temperature of employees every day to ensure the health of employees. These measures will increase the production cost of enterprises and affect the development of enterprises.

Strength

The demand of downstream patients for Fluorescence Immunoassay Poc Analyzers will increase continuously
Growing Demand from Key Regions

Weakness

Disadvantages of Fluorescence Immunoassay Poc Analyzers
POCT industry has the characteristics of large investment scale, long R&D cycle, high risk and high added value.

Opportunities

Active medical equipment policy
The convenience of Internet and the development of e-commerce

Threat

The government's supervision policy
Competition in the industry is fierce

Region Overview:

North America had the highest growth rate of all regions.

Company Overview:

Siemens is one of the major players operating in the Fluorescence Immunoassay Poc Analyzers market, holding a share of 15.83% in 2021.

Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services.

Quidel Corporation is a California-based leading diagnostic healthcare manufacturer serving to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system. Quidel is delivering a continuum of diagnostic solutions from advanced lateral-flow and direct fluorescent antibody to molecular diagnostic tests that further improve the quality of healthcare.

Segmentation Overview:

Among different product types, Non-Portable POC Analyzers segment is anticipated to contribute the largest market share in 2027.

Application Overview:

By application, the Medical segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Fluorescence Immunoassay Poc Analyzers market covered in Chapter 3:

Siemens
Bio-Rad Laboratories
Merck
Trinity Biotech Plc
SD Biosensor
BioMérieux
Chembio Diagnostic
Quidel
Sysmex Corporation

In Chapter 4 and Chapter 14.2, on the basis of types, the Fluorescence Immunoassay Poc Analyzers market from 2018 to 2029 is primarily split into:

Portable POC Analyzers
Non-Portable POC Analyzers

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Fluorescence Immunoassay Poc Analyzers market from 2018 to 2029 covers:

Medical
Veterinary
Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)